Bâloise Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLHEY research report →
Price Chart
About the company
Bâloise Holding AG functions as a multifaceted financial services group, primarily concentrating its efforts in the insurance and banking industries across key European markets including Switzerland, Germany, Belgium, and Luxembourg. The company organizes its extensive operations into distinct divisions: Non-Life, Life, Asset Management & Banking, and Other Activities. Its non-life insurance offerings are comprehensive, providing policies for accidents, health, general liability, motor vehicles, fire and property damage, marine activities, credit protection, and legal expenses.
- CEO
- Michael Muller
- IPO
- 2009
- Employees
- 7,693
- HQ
- Basel, CH
Get TickerSpark's AI analysis on BLHEY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.07B
- P/E
- 23.35
- Fwd P/E
- 20.08
- PEG
- 0.32
- P/S
- 1.41
- P/B
- 2.48
- EV/EBITDA
- 19.43
- Div Yield
- 4.09%
- Gross Margin
- 100.00%
- Op Margin
- 8.18%
- Net Margin
- 6.05%
- ROE
- 11.19%
- ROIC
- 0.50%
Latest fiscal year · YoY change
- Revenue
- $6.36B-8.6%
- Gross Profit
- $6.36B-10.6%
- Op Income
- $520.50M
- Net Income
- $384.80M+60.6%
- EPS
- $0.85+60.7%
- OCF Growth
- -75.3%
- FCF Growth
- -86.9%
- 52W High
- $27.95
- 52W Low
- $19.00
- 50D MA
- $25.71
- 200D MA
- $23.85
- Beta
- 0.45
- RSI (14)
- 28
- Avg Volume
- 245
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Baloise said its refocusing plan is on track, with improved profitability, stronger cash generation, and merger preparations with Helvetia progressing toward a year-end close.· September 10, 2025
- Net profit rose 26% to CHF 276 million, while return on equity increased from 13% to 15.5%.
- The non-life combined ratio improved 2.6 percentage points to 90.6%, helped by better loss experience and fewer nat cat events.
- Non-life growth was strongest in target segments, with 3.1% local-currency growth in adjusted non-life and 41.2% growth in investment-type premiums.
- Management said the refocusing program is ahead of plan, with more than 50% of the targeted 250 FTE reduction already achieved after one year.
- The planned Helvetia merger remains on track for Q4 year-end completion, with financial targets to be shared at a later Capital Markets Day.
Baloise reported net profit of CHF 276 million, up 26% year over year. The non-life combined ratio improved by 2.6 percentage points to 90.6%; non-life EBIT reached CHF 229 million, up 85.6%; Life EBIT was CHF 143 million, stable versus last year; and Asset Management & Banking EBIT rose 18.4% to CHF 50 million. Return on equity rose from 13% in H1 2024 to 15.5%, and the estimated SST ratio improved to around 215%. Forward-looking, management reiterated that it remains on track to remit more than CHF 2 billion of cash for the period 2024 to 2027, and said the Helvetia merger is expected to close in Q4 by year-end, with combined-group financial targets to be disclosed at the Capital Markets Day next year alongside full-year 2025 results.
CEO Michael Müller framed the half year as evidence that Baloise’s refocusing strategy is working and said the company is making sustainable progress one year into the plan. He emphasized stronger technical profitability, operational efficiency, and disciplined portfolio steering, while noting that the merger with Helvetia is proceeding as planned. His tone was confident and measured, with repeated comments that the company is “fully on track” but still has work ahead on portfolio optimization and integration.
CFO Carsten Stolz highlighted improved profitability across the group, including net profit of CHF 276 million, a 90.6% combined ratio in non-life, and Life EBIT of CHF 143 million. He pointed to growth in target segments, including 3.1% local-currency non-life growth adjusted for Belgium portfolio exits, 41.2% growth in investment-type premiums, and a 60.3% cost/income ratio in banking. He also said the group remains on track to remit more than CHF 2 billion of cash from 2024 to 2027, noted the SST ratio at around 215%, and reminded investors that merger-related integration costs will run over the next few years, with CHF 500 million to CHF 600 million previously indicated.
Analysts focused on the lower Life new business margin, German non-life growth, the “other” EBIT line, Belgian profitability, and the sustainability of property revaluation gains. Management said the lower Life margin was mainly due to business mix, especially more capital-light products, while German non-life growth was driven slightly more by price than volume. On the cost line, management said merger and refocusing-related costs were flowing through there, but did not disclose the amount; on property, CIO Matthias Henny said the Swiss real estate uplift was above 2% and should be supported by favorable market fundamentals.
The bull case from this call is that the refocusing strategy appears to be translating into better earnings quality rather than just top-line growth. Non-life profitability improved sharply, capital remains strong, cash remittance remains on track, and management sounded confident that the Helvetia combination can create additional synergy and dividend capacity over time. The company also described momentum in selected target segments such as investment-type premiums, banking, and third-party asset management.
The main risks are that growth is intentionally muted in some lines as Baloise prioritizes profitability over volume, especially in Life and parts of Non-life. Management also flagged continuing merger and restructuring costs, lower Life new business margin due to business mix, and reduced Life premiums from the shift toward semi-autonomous solutions. Investors were told that the full impact of the merger, dividend policy, and future integration costs will only become clearer after closing and at next year’s Capital Markets Day.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 10.0%
- Shares Outstanding
- 454.09M
- Float Shares
- 45.35M
Our BLHEY coverage
Recent articles, reports, and earnings notes.
No research on BLHEY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLHEY report →Swiss insurer Helvetia Baloise to cut up to 2,600 jobs following merger
reuters.com · Dec 9
Bâloise (OTCMKTS:BLHEY) Stock Price Down 1.3% – Should You Sell?
defenseworld.net · Nov 18
Baloise Holding AG (BLHEY) Q2 2025 Earnings Call Transcript
seekingalpha.com · Sep 10
Top Baloise Investor Cevian Sells Stake to Helvetia Shareholder Ahead of Merger Deal
wsj.com · Apr 25
Baloise says Patria acquires 9.35% stake from Cevian ahead of merger with Helvetia
reuters.com · Apr 25
Helvetia, Baloise to Merge to Create Switzerland's Second-Largest Insurer
wsj.com · Apr 22
Helvetia and Baloise to merge, creating Switzerland's second-biggest insurance group
reuters.com · Apr 22
Swiss insurers Baloise, Helvetia explore merger, Bloomberg News reports
reuters.com · Mar 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.